BGood

Pfizer, Inc.(PFE)

B

Financial data as of Dec 31, 2024Declining · Healthcare

FCF Margin15.5%Free Cash Flow / Revenue
Cash Conversion158.7%Operating CF / Net Income
Free Cash Flow$9.8B
Revenue$63.6B
Net Cash-$62.6BNet debt position
Debt / FCF6.5xElevated debt burden
Current Ratio1.17Adequate short-term liquidity
YoY FCF Growth-34.0%4 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseA
-0.5Elevated debt-to-FCF ratio (6.5x)
+0.5Healthy FCF margin with manageable debt (15.5%, 6.5x)
-1Significant YoY FCF decline (-34.0%)
-0.5Highly volatile FCF (consistency: 0.83)
FinalB

Analysis Summary

Strengths

  • Strong FCF margin (15.5%)
  • Excellent cash conversion (159%)

Concerns

  • Heavy debt position ($62.6B)
  • High debt-to-FCF ratio (6.5x)
  • Significant YoY FCF decline (-34.0%)
  • Highly volatile quarterly FCF
  • Significant FCF decline (-34.0% YoY)

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin15.5%
Net Margin12.6%
Operating CF Margin20.0%
CapEx Ratio4.6%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash-$62.6BNet debt position
Debt / FCF6.5xElevated debt burden
Current Ratio1.17Adequate liquidity
Debt / Equity0.72Low leverage

Quarterly FCF Trend

-34.0% YoYDeclining (-34.0%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NamePfizer, Inc.
SectorHealthcare
Free Cash Flow$9.8B
Revenue$63.6B
Net Income$8.0B
Operating Cash Flow$12.7B
Capital Expenditure$2.9B
FCF Margin15.5%
Cash Conversion Rate158.7%
Net Margin12.6%
Total Debt$63.6B
Total Cash$1.0B
Net Cash-$62.6B
Current Ratio1.17
Debt / Equity0.72
Debt / FCF6.5x
YoY FCF Growth-34.0%
Positive Quarters4 of 5
Trend DirectionDeclining
Report DateDec 31, 2024
GradeB
Data SourceYahoo Finance